FR3626M - Médicament pour affections intestinales. - Google Patents

Médicament pour affections intestinales.

Info

Publication number
FR3626M
FR3626M FR974500A FR974500A FR3626M FR 3626 M FR3626 M FR 3626M FR 974500 A FR974500 A FR 974500A FR 974500 A FR974500 A FR 974500A FR 3626 M FR3626 M FR 3626M
Authority
FR
France
Prior art keywords
compositions
mucin
acid
sialic acid
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR974500A
Other languages
English (en)
Inventor
Lucien Nouvel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR953570A external-priority patent/FR3554M/fr
Application filed by Individual filed Critical Individual
Priority to FR974500A priority Critical patent/FR3626M/fr
Priority to GB45965/64A priority patent/GB1077136A/en
Priority to BE655608D priority patent/BE655608A/xx
Priority to IL22443A priority patent/IL22443A/en
Application granted granted Critical
Publication of FR3626M publication Critical patent/FR3626M/fr
Priority to US732497A priority patent/US3567821A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1735—Mucins, e.g. human intestinal mucin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR974500A 1963-11-13 1964-05-14 Médicament pour affections intestinales. Expired FR3626M (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR974500A FR3626M (fr) 1963-11-13 1964-05-14 Médicament pour affections intestinales.
GB45965/64A GB1077136A (en) 1963-11-13 1964-11-11 Medicament for affections of mucous membranes
BE655608D BE655608A (fr) 1963-11-13 1964-11-12
IL22443A IL22443A (en) 1963-11-13 1964-11-13 A medicament for protection of mucous membranes
US732497A US3567821A (en) 1963-11-13 1968-05-23 Medicament for the affections of mucous membranes

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR953570A FR3554M (fr) 1963-11-13 1963-11-13 Protecteur des muqueuses.
FR974500A FR3626M (fr) 1963-11-13 1964-05-14 Médicament pour affections intestinales.

Publications (1)

Publication Number Publication Date
FR3626M true FR3626M (fr) 1965-10-18

Family

ID=26204309

Family Applications (1)

Application Number Title Priority Date Filing Date
FR974500A Expired FR3626M (fr) 1963-11-13 1964-05-14 Médicament pour affections intestinales.

Country Status (5)

Country Link
US (1) US3567821A (fr)
BE (1) BE655608A (fr)
FR (1) FR3626M (fr)
GB (1) GB1077136A (fr)
IL (1) IL22443A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1279820A (en) * 1968-12-26 1972-06-28 Nissui Pharm Co Ltd Process for preparing mucoprotein and product obtained thereby
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
CH637297A5 (fr) * 1978-12-05 1983-07-29 Nestle Sa Microbille comprenant un microorganisme et son procede de fabrication.
EP0050644B1 (fr) 1980-04-25 1985-09-18 A/S Orthana Kemisk Fabrik Solutions sterilisees, preservees, stables, et contenant de la mucine et procede de sterilisation
DK155569C (da) * 1980-04-25 1989-10-09 Orthana Kemisk Fab As Fremgangsmaade til fremstilling af steriliserede, praeserverede, stabile mucinholdige praeparater
US4983163A (en) * 1981-10-09 1991-01-08 Science Research Center, Inc. Method, compositions and articles for prevention and treatment of herpes simplex virus infections
JPS5927833A (ja) * 1982-08-06 1984-02-14 Advance Res & Dev Co Ltd コレステロール乃至トリグリセリド低下剤
JPS59122428A (ja) * 1982-12-28 1984-07-14 Advance Res & Dev Co Ltd コレステロ−ル低下活性蛋白質
JPS615022A (ja) * 1984-06-19 1986-01-10 Advance Res & Dev Co Ltd 腸内細菌叢改善剤
JPS61151128A (ja) * 1984-12-24 1986-07-09 Advance Res & Dev Co Ltd コレステロ−ル低下活性ｒｎａ画分
JPS625991A (ja) * 1985-07-03 1987-01-12 Advance Res & Dev Co Ltd コレステロ−ル乃至トリグリセリド低下活性ｒｎａ画分
US5804179A (en) * 1985-12-31 1998-09-08 Research Corporation Technologies, Inc. Lactobacillus compositions and methods for treating urinary tract infections
AT407008B (de) * 1998-08-06 2000-11-27 Viernstein Helmut Dr Formulierungen mit probiotisch wirksamen mikroorganismen
US20060073154A1 (en) * 2001-09-04 2006-04-06 The Rockfeller University Group a streptococci bind to mucin and human pharyngeal cells through a sialic acid-containing receptor
US20080003330A1 (en) * 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
CN102526696B (zh) * 2012-02-13 2013-09-11 合肥今越制药有限公司 一种胃膜素胶囊的组合物及其制备方法

Also Published As

Publication number Publication date
IL22443A (en) 1968-04-25
GB1077136A (en) 1967-07-26
US3567821A (en) 1971-03-02
BE655608A (fr) 1965-05-12

Similar Documents

Publication Publication Date Title
FR3626M (fr) Médicament pour affections intestinales.
US3369969A (en) Colibacilli containing medicament and a method of preparing same
JP3430853B2 (ja) 胃炎、胃潰瘍および十二指腸潰瘍の予防剤並びに治療剤
JP3140049B2 (ja) 病原性腸内細菌をコントロールするための医薬製剤
CN105358166B (zh) 用于反刍动物的乳腺炎的预防剂或治疗剂
CN1192151A (zh) 药用的微胶囊化乳芽孢杆菌
US12214005B2 (en) Probiotic composition for prevention of bacterial vaginosis
RU2130316C1 (ru) Лечебно-профилактический биопрепарат "бактиспорин"
JP2005501863A (ja) 細菌またはウイルス感染症の予防または治療における乳清アポタンパク質の使用
Kalb et al. Cutaneous infection at dog bite wounds associated with fulminant DF-2 septicemia
WO2019212244A1 (fr) Protéine recombinante dérivée d'un bactériophage ayant une activité antimicrobienne contre des bactéries à gram négatif pathogènes
Kelstrup et al. Inactivation of bacteriocins in the intestinal canal and oral cavity
SE9704584L (sv) Framställning av konjugerad linolsyra
JP2832517B2 (ja) 大腸菌付着阻止剤
WO2025252192A1 (fr) Production et utilisation d'une protéine antibactérienne ciblant propionibacterium acnes
Gerber et al. Worldwide clinical experience with cefoperazone
RU2123345C1 (ru) Средство для лечения дисбактериоза
WO2021002697A2 (fr) Utilisation de protéine antibactérienne de recombinaison ablysine pour éliminer efficacement des bactéries pathogènes multirésistantes aux antibiotiques
WO2020055011A1 (fr) Utilisation d'une enzyme antibactérienne recombinante lyssap26 pour tuer efficacement des bactéries pathogènes
Nolen et al. Comparison of aztreonam and tobramycin in the treatment of lower respiratory tract infections caused by gram-negative bacilli
CN119219744B (zh) 抗菌肽及其应用
JPH10108672A (ja) ビフィズス因子の活性増強・安定化剤
Cox Cefazolin therapy of urinary tract infections
CN115724939A (zh) 阳离子蛋白质及其制备方法
EP1082096A1 (fr) Compositions de traitement pour la peau et leur utilisation